CLERIVY's U.S. debut includes a hydrocolloid patch and a water-soluble microdart patch featuring niacinamide, tranexamic acid and a vitamin C derivative. A separate OTC acne patch with 2% salicylic acid is scheduled for release in October 2026. SEOUL, South Korea, , Aug. 26, 2026 /PRNewswire/ -- Korean skincare...
KUALA LUMPUR, Malaysia, Jan. 14, 2025 /PRNewswire/ -- The Malaysian Society for Quality in Health (MSQH), a leading national healthcare accreditation body dedicated to...
HO CHI MINH CITY, Vietnam, Jan. 14, 2025 /PRNewswire/ -- GlobalTix, Asia's leading ticketing and marketplace distribution platform, has been named "Growth Partner of...
MELBOURNE, Australia, Jan. 14, 2025 /PRNewswire/ -- As Australia's retail trading market matures, the focus is shifting beyond regulatory compliance to a broader culture...
O-RAN ALLIANCE Extended Board of Directors has been elected for the upcoming 2-year term
Abdurazak Mudesir, Group CTO of Deutsche Telekom, was re-elected...
MELBOURNE, Australia and INDIANAPOLIS, Jan. 14, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today advises that Dr. Christian Behrenbruch,...
